Your browser doesn't support javascript.
loading
Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Huang, Yinshi; Nahar, Sabikun; Nakagawa, Akifumi; Fernandez-Barrena, Maite G; Mertz, Jennifer A; Bryant, Barbara M; Adams, Curtis E; Mino-Kenudson, Mari; Von Alt, Kate N; Chang, Kevin; Conery, Andrew R; Hatton, Charlie; Sims, Robert J; Fernandez-Zapico, Martin E; Wang, Xingpeng; Lillemoe, Keith D; Fernández-Del Castillo, Carlos; Warshaw, Andrew L; Thayer, Sarah P; Liss, Andrew S.
Affiliation
  • Huang Y; Departments of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, P.R. China. Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachuset
  • Nahar S; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Nakagawa A; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Fernandez-Barrena MG; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
  • Mertz JA; Constellation Pharmaceuticals, Cambridge, Massachusetts.
  • Bryant BM; Constellation Pharmaceuticals, Cambridge, Massachusetts.
  • Adams CE; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Von Alt KN; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Chang K; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Conery AR; Constellation Pharmaceuticals, Cambridge, Massachusetts.
  • Hatton C; Constellation Pharmaceuticals, Cambridge, Massachusetts.
  • Sims RJ; Constellation Pharmaceuticals, Cambridge, Massachusetts.
  • Fernandez-Zapico ME; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
  • Wang X; Departments of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, P.R. China. Departments of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiatong University School of Medicine, Shanghai, P.R. China.
  • Lillemoe KD; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Fernández-Del Castillo C; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Warshaw AL; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Thayer SP; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. aliss@mgh.harvard.edu sarah.thayer@unmc.edu.
  • Liss AS; Department of Surgery and the Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. aliss@mgh.harvard.edu sarah.thayer@unmc.edu.
Clin Cancer Res ; 22(16): 4259-70, 2016 Aug 15.
Article in En | MEDLINE | ID: mdl-27169995

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / RNA-Binding Proteins / Tumor Microenvironment / Zinc Finger Protein GLI1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / RNA-Binding Proteins / Tumor Microenvironment / Zinc Finger Protein GLI1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: